7/23/2013 11:00:04 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
AstraZeneca Plc (AZN), Pfizer Inc. and Novartis AG (NOVN) are among the suitors preparing bids for Onyx Pharmaceuticals Inc. (ONXX), the drugmaker that snubbed an unsolicited offer from Amgen (AMGN) Inc., said two people familiar with the matter. The companies, which signed confidentiality agreements and hired advisers, may make first-round bids this week, according to the people, who asked not to be named because the process is private. Onyx disclosed last month that it’s working with advisers on finding bidders following its rejection of Amgen’s bid of $120 a share.
Help employers find you! Check out all the jobs and post your resume.
comments powered by